Consolidated Portfolio Review Corp’s Healthcare Realty HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-55,786
Closed -$1.01M 193
2025
Q3
$1.01M Buy
55,786
+637
+1% +$10.8K 0.13% 178
2025
Q2
$875K Buy
55,149
+2,035
+4% +$30.9K 0.12% 183
2025
Q1
$898K Sell
53,114
-2,219
-4% -$36.9K 0.14% 162
2024
Q4
$938K Buy
55,333
+808
+1% +$14.2K 0.15% 162
2024
Q3
$990K Buy
54,525
+496
+0.9% +$8.79K 0.22% 119
2024
Q2
$890K Buy
54,029
+9,227
+21% +$141K 0.21% 120
2024
Q1
$634K Buy
44,802
+6,726
+18% +$101K 0.17% 141
2023
Q4
$656K Buy
+38,076
New +$581K 0.15% 148

Other funds holding HR

Consolidated Portfolio Review Corp's HR Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of Healthcare Realty (HR) in Q4 2025, closing a stake of 55,786 shares — an estimated $1.01M sold.

Consolidated Portfolio Review Corp first reported a position in HR in Q4 2023 and held it in 8 quarters. The position peaked at $1.01M in Q3 2025. 422 funds tracked by Wall St. Rank hold HR as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining Healthcare Realty position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 55,786 Healthcare Realty shares in Q4 2025, an estimated $1.01M.
  • Consolidated Portfolio Review Corp first reported a position in Healthcare Realty in Q4 2023 and held it in 8 quarters.
  • Consolidated Portfolio Review Corp's Healthcare Realty position peaked at $1.01M in Q3 2025.
  • 422 funds tracked by Wall St. Rank held Healthcare Realty as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.